Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Change in Accured Expenses (2019 - 2026)

ADC Therapeutics has reported Change in Accured Expenses over the past 8 years, most recently at -$3.2 million for Q1 2026.

  • Quarterly results put Change in Accured Expenses at -$3.2 million for Q1 2026, up 84.57% from a year ago — trailing twelve months through Mar 2026 was $10.0 million (up 268.59% YoY), and the annual figure for FY2025 was -$7.4 million, down 166.61%.
  • Change in Accured Expenses reached -$3.2 million in Q1 2026 per ADCT's latest filing, down from $2.0 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $16.2 million in Q4 2022 and bottomed at -$20.6 million in Q1 2025.
  • Median Change in Accured Expenses over the past 5 years was -$519000.0 (2023), compared with a mean of $176052.7.
  • The largest annual shift saw Change in Accured Expenses tumbled 9584.65% in 2023 before it skyrocketed 1172.64% in 2024.
  • Over 5 years, Change in Accured Expenses stood at $16.2 million in 2022, then tumbled by 87.91% to $2.0 million in 2023, then skyrocketed by 475.61% to $11.3 million in 2024, then crashed by 82.54% to $2.0 million in 2025, then crashed by 261.25% to -$3.2 million in 2026.
  • Business Quant data shows Change in Accured Expenses for ADCT at -$3.2 million in Q1 2026, $2.0 million in Q4 2025, and -$799000.0 in Q3 2025.